NCT02290210 Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients Status COMPLETED Phase PHASE2
NCT02287818 A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout Status COMPLETED Phase PHASE2
NCT02279641 RDEA3170 and Allopurinol Combination Study in Gout Subjects Status COMPLETED Phase PHASE1
NCT02252835 Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout Status COMPLETED Phase PHASE2
NCT02187029 Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. Status TERMINATED Phase PHASE1
NCT02139046 Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout Status COMPLETED Phase PHASE3
NCT02128490 Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment Status COMPLETED Phase PHASE2
NCT02082769 Safety and Efficacy of Oral Febuxostat in Subjects With Gout Status COMPLETED Phase PHASE3
NCT02063997 Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients Status COMPLETED Phase PHASE2
NCT02037321 Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk Status ACTIVE_NOT_RECRUITING Phase N/A